Hepatitis C virus (HCV) causes hepatitis C either in an acute or chronic form in the liver. Acute HCV viruses are, in most cases, asymptomatic and pose no threat to life. Approximately 30% of the HCV infected people can get rid of the virus from their body within six months with no treatment.
If the body cannot get rid of the virus, it will develop chronic HCV liver infection. The chances of getting liver cirrhosis once the disease has become chronic are about 15-30%.
There is no vaccine to protect against HCV. So, the only way to avoid getting infected is to reduce the risk of exposure to the disease willingly.
Experts around the world suggest several preventive measures.
These measures include:
There is no treatment in the initial stages because our immune system can get rid of the virus from the body. If the infection becomes chronic, Liver Damage treatment is a must.
WHO recommends therapy that involves pan-genotypic DAAs for patients over 12. DAA, in most cases, cures the patients within a short duration of 12 to 24 weeks, provided there is no cirrhosis.
Pan-genotypic DAAs are often costly and are not available to everyone. However, there has been a drop in the prices in some liver transplant hospitals in Chennai. Though the demand-supply gap has improved, the drug has not yet become available to everyone.